Deaminet 2026: Breakthroughs in Base Editing, Deaminase Biology, and Therapeutic Translation
Type
Blog Post
Published
March 10, 2026, 1:14 p.m.
...improvement comes with a trade-off: overextension past the reverse transcriptase (RT) template, resulting...presented oDNA: circular single-stranded DNA with short double-stranded regions just long enough for recombinase...metabolic comorbidities, demonstrating tunable, re-dosable control of therapeutic transgenes via endogenous ADAR...resolution
PE6d: Processivity gains and overextension trade-offs
The prime editor PE6d exhibits substantially... implicate specific residues in the reverse transcriptase polymerase domain as likely determinants of ...using a novel chemistry. This approach achieves ultra-low false-positive (0–9%) and false-negative (0–...types.
3. From bench to bedside: Therapeutic translation is accelerating
Base editors and prime editors...